RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
55 hedge funds and large institutions have $140M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 12 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
55
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$7.99M | |
| 2 | +$1.55M | |
| 3 | +$1.35M | |
| 4 |
Luther King Capital Management (LKCM)
Fort Worth,
Texas
|
+$1.27M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$1.02M |
Top Sellers
| 1 | -$497K | |
| 2 | -$328K | |
| 3 | -$285K | |
| 4 |
Millennium Management
New York
|
-$259K |
| 5 |
DTL
Dynamic Technology Lab
Singapore
|
-$216K |